S. Piroso

发表

Pain‐processing abnormalities in bipolar I disorder, bipolar II disorder, and schizophrenia: A novel trait marker for psychosis proneness and functional outcome?

G. Cruccu, F. S. Bersani, A. Minichino, 2016, Bipolar disorders.

Rationale for use of onabotulinum toxin A (BOTOX) in chronic migraine

P. Barbanti, G. Egeo, C. Aurilia, 2015, Neurological Sciences.

Clinical, neurophysiological, and skin biopsy findings in peripheral neuropathy associated with hepatitis C virus-related cryoglobulinemia

G. Cruccu, A. Truini, G. Di Stefano, 2014, Journal of Neurology.

N-acetyl-cysteine, a drug that enhances the endogenous activation of group-II metabotropic glutamate receptors, inhibits nociceptive transmission in humans

F. Nicoletti, G. Cruccu, G. Battaglia, 2015, Molecular pain.

Migraine and sleep disorders: a systematic review

S. Sacco, P. Martelletti, S. Piroso, 2020, The Journal of Headache and Pain.

Does the epidermal nerve fibre density measured by skin biopsy in patients with peripheral neuropathies correlate with neuropathic pain?

G. Cruccu, A. Truini, C. Giordano, 2014, PAIN®.

Chronic migraine: treatability, refractoriness, pseudo-refractoriness

P. Barbanti, G. Egeo, C. Aurilia, 2015, The Journal of Headache and Pain.

61. Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain

G. Cruccu, A. Truini, A. Pepe, 2015, Clinical Neurophysiology.